Search by Drug Name or NDC

    NDC 46122-0531-52 Allergy Relief 5 mg/1 Details

    Allergy Relief 5 mg/1

    Allergy Relief is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by AMERISOURCEBERGEN DRUG CORPORATION. The primary component is LEVOCETIRIZINE DIHYDROCHLORIDE.

    Product Information

    NDC 46122-0531
    Product ID 46122-531_7ac146e8-8009-f57f-2966-5fac830d67b9
    Associated GPIs 41550027100320
    GCN Sequence Number 048920
    GCN Sequence Number Description levocetirizine dihydrochloride TABLET 5 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 14901
    HICL Sequence Number 022959
    HICL Sequence Number Description LEVOCETIRIZINE DIHYDROCHLORIDE
    Brand/Generic Generic
    Proprietary Name Allergy Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name levocetirizine dihydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LEVOCETIRIZINE DIHYDROCHLORIDE
    Labeler Name AMERISOURCEBERGEN DRUG CORPORATION
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210375
    Listing Certified Through 2024-12-31

    Package

    NDC 46122-0531-52 (46122053152)

    NDC Package Code 46122-531-52
    Billing NDC 46122053152
    Package 2 BLISTER PACK in 1 CARTON (46122-531-52) / 5 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2018-07-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.17703
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GNP ALLERGY RELIEF 5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis